ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 91 filers reported holding ADICET BIO INC in Q1 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,810,817 | -43.6% | 4,241,472 | 0.0% | 0.12% | -37.2% |
| Q2 2023 | $10,306,777 | -57.8% | 4,241,472 | 0.0% | 0.20% | -61.5% |
| Q1 2023 | $24,430,879 | -35.6% | 4,241,472 | 0.0% | 0.51% | -34.2% |
| Q4 2022 | $37,918,760 | -37.1% | 4,241,472 | 0.0% | 0.77% | -44.3% |
| Q3 2022 | $60,314,000 | +4.6% | 4,241,472 | +7.3% | 1.39% | -6.8% |
| Q2 2022 | $57,689,000 | -3.4% | 3,951,281 | +32.2% | 1.49% | +20.6% |
| Q1 2022 | $59,700,000 | +12.9% | 2,989,482 | -1.1% | 1.24% | +60.1% |
| Q4 2021 | $52,885,000 | – | 3,023,744 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |